EMBC (Embecta) Buyback Yield % : 0.00 (As of Apr. 23, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Embecta's current buyback yield was 0.00%.

Embecta Buyback Yield % Historical Data

The historical data trend for Embecta's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Buyback Yield % Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Buyback Yield %

Get a 7-Day Free Trial

Embecta Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of Embecta's Buyback Yield %

For the Medical Instruments & Supplies subindustry, Embecta's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embecta's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Embecta's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Embecta Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Embecta's Buyback Yield for the fiscal year that ended in Sep. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	813.6687
	=	0.00%

Embecta's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	1200.4258
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Embecta Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Embecta's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (NAS:EMBC) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Executives

David F Melcher	director	1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Milton Mayo Morris	director	2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Devdatt Kurdikar	officer: President and CEO	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jacob Elguicze	officer: Chief Financial Officer	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey Z Mann	officer: SVP, GC, Head Corp. Dev., Secy	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Jean Casner	officer: Chief Human Resources Officer	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Ajay Kumar	officer: SVP and CHRO	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Shaun Curtis	officer: SVP, Global Manuf./Sup. Chain	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Albritton	director	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880
Brian Capone	officer: VP, CAO & Corp. Controller	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Carrie L Anderson	director	3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515
Claire Pomeroy	director	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Robert J. Hombach	director	C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015